Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-04-009681
Filing Date
2004-11-09
Accepted
2004-11-09 16:49:36
Documents
6
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PERIOD ENDED SEPTEMBER 30, 2004 a03108e10vq.htm 10-Q 532362
2 EXHIBIT 15.1 a03108exv15w1.htm EX-15.1 2880
3 EXHIBIT 15.2 a03108exv15w2.htm EX-15.2 1453
4 EXHIBIT 31.1 a03108exv31w1.htm EX-31.1 4882
5 EXHIBIT 31.2 a03108exv31w2.htm EX-31.2 4864
6 EXHIBIT 32.1 a03108exv32w1.htm EX-32.1 3860
  Complete submission text file 0000950137-04-009681.txt   552618
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11397 | Film No.: 041130219
SIC: 2834 Pharmaceutical Preparations